CAA |
cancer-associated adipocyte |
TME |
tumor microenvironment |
COX-2 |
cyclooxygenase-2 |
NSAID |
nonsteroidal anti-inflammatory drug |
FA |
fatty acid |
BMI |
body mass index |
PG |
prostaglandin |
PPAR |
peroxisome proliferator-activated receptor |
C/EBP |
CCAAT enhancer binding protein |
IL |
interleukin |
TNFα |
tumor necrosis factor α |
FFA |
free fatty acid |
FAO |
fatty acid oxidation |
TG |
triacylglycerol |
MMP |
matrix metalloproteinase |
CCL2 |
chemokine ligand 2 |
VEGF |
vascular endothelial growth factor |
ECM |
extracellular matrix |
EMT |
epithelial-mesenchymal transition |
IGF |
insulin-like growth factor |
IGFBP |
IGF binding protein |
AP1 |
activator protein-1 |
MSC |
mesenchymal stem cell |
CiDA |
compression-induced dedifferentiated adipocytes |
LPS |
liposarcoma |
AP2 |
adipocyte protein 2 |
TGFβ |
transforming growth factor β |
MCP1 |
monocyte chemoattractant protein-1 |
PPRE |
PPAR response element |
PLIN1 |
perilipin1 |
HSL |
hormone sensitive lipase |
CCR2 |
C-C chemokine receptor type 2 |
cAMP |
cyclic AMP |
PKA |
protein kinase A |
ATGL |
adipose triglyceride lipase |
JAK |
Janus kinase |
STAT |
signal transducer and activator of transcription |
EV |
extracellular vesicle |
FAP |
familial adenomatous polyposis |
OR |
odds ratio |
CI |
confidence interval |
HR |
hazard ratio |